on this subject, do yourselves a favour, watch the webinar again. This time just fast forward through whenever LC talks. Lets be honest she added nothing knew and serveral times just made it awkward when she would fumble through/ not knowing what the questions were or worse how to answer them. Not a LC hater but she is the captain so therefore ultimately responsible. Keep to running the company, let someone else communicate what the company is doing to the holders. Not just scripted recycled crap time after time. Whats working, whats not yet.... the plan moving forward. Its not a bad watch with lc skipped.
Can only imagine how it would sound if someone would say, Just a quick update peopleof where things are at.
CF33.... YEP it would have been great if it had obliterated all cancers as it did in mice. BUT remember people are not mice, there are differences, We are still working upto optimum dose levels. working out how we can work tweek it add combo's. Its far from a dead weight, we are trying this... because we think this....
PD1, sure pre op trial delayed but not dead. When it happens it could be a game changer on opening doors for trialling all of our lines that have proven zero toxicities.
Azer-cel, As you are all aware, after tweeking the 1b trial we are at 4 from 7 crs. This is outstanding, sure this could take 2-3 yrs to complete but we are dosing more patients soon.( or already have) Our 4 from 7 has gained us a lot more exposure inside the medical fraternity, 12 months ago we were offering an unproven product to patients who had failed upto 7 previous products which we have still managed to get crs from but now we are offering a product that you have a 58% cr chance. We hope/ expect to get patients that are not now viewing this as a " why not try it i have nothing to loose " but " ok Doc so standard of care has failed, whats out there that giving people a chance??? " Therefore giving us healthier patients to choose from.
HERVAX yes we still have it. Its still on the market, these things take time, there is still some interest as it is still a product that can improve life expectancy by 40%
That all the updates for this qtr. We will keep you updated if anything happens and look forward to giving you our next update in 3 months.
Aaahhhhh just imagine.
IMU Price at posting:
2.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)